Last updated: 8 December 2020 at 9:27am EST

International Plc Endo Net Worth




The estimated Net Worth of International Plc Endo is at least $8.85 Tisíc dollars as of 2 December 2020. International Endo owns over 7,344,955 units of Biospecifics Technologies stock worth over $8,853 and over the last 4 years International sold BSTC stock worth over $0.

International Endo BSTC stock SEC Form 4 insiders trading

International has made over 1 trades of the Biospecifics Technologies stock since 2020, according to the Form 4 filled with the SEC. Most recently International bought 7,344,955 units of BSTC stock worth $650,028,518 on 2 December 2020.

The largest trade International's ever made was buying 7,344,955 units of Biospecifics Technologies stock on 2 December 2020 worth over $650,028,518. On average, International trades about 7,344,955 units every 0 days since 2020. As of 2 December 2020 International still owns at least 100 units of Biospecifics Technologies stock.

You can see the complete history of International Endo stock trades at the bottom of the page.



What's International Endo's mailing address?

International's mailing address filed with the SEC is FIRST FLOOR, MINERVA HOUSE,, SIMMONSCOURT ROAD, BALLSBRIDGE, DUBLIN 4, L2, .

Insiders trading at Biospecifics Technologies

Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo a Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.

Complete history of International Endo stock trades at Biospecifics Technologies

Človek
Trans.
Transakcia
Celková cena
International Plc Endo
10% vlastník
Kúpa $650,028,518
2 Dec 2020


Biospecifics Technologies executives and stock owners

Biospecifics Technologies executives and other stock owners filed with the SEC include: